BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11776720)

  • 1. Seroprevalence of Schistosoma mansoni in Puerto Ricans with inflammatory bowel disease.
    Torres EA; Acosta H; Cruz M; Weinstock J; Hillyer GV
    P R Health Sci J; 2001 Sep; 20(3):211-4. PubMed ID: 11776720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of inflammatory bowel disease in an insured population in Puerto Rico during 1996.
    Torres EA; De Jesús R; Pérez CM; Iñesta M; Torres D; Morell C; Just E
    P R Health Sci J; 2003 Sep; 22(3):253-8. PubMed ID: 14619451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Geographic clustering and seroprevalence of schistosomiasis in Puerto Rico (1995).
    Tsang VC; Hillyer GV; Noh J; Vivas-Gonzalez BE; Ahn LH; Pilcher JB; Hightower AW; Deseda C; de Melecio CF
    Am J Trop Med Hyg; 1997 Jan; 56(1):107-12. PubMed ID: 9063371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of spondyloarthropathy in Puerto Rican patients with inflammatory bowel disease.
    Rodriguez VE; Costas PJ; Vazquez M; Alvarez G; Perez-Kraft G; Climent C; Nazario CM
    Ethn Dis; 2008; 18(2 Suppl 2):S2-225-9. PubMed ID: 18646354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
    Mokrowiecka A; Gasiorowska A; Małecka-Panas E
    Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases].
    Mekkel G; Barta Z; Ress Z; Gyimesi E; Sipka S; Zeher M
    Orv Hetil; 2005 Apr; 146(17):797-802. PubMed ID: 17918636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
    Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteoporosis in inflammatory bowel disease - results of a survey among members of the German Crohn's and Ulcerative Colitis Association].
    von Tirpitz C; Steder-Neukamm U; Glas K; Sander S; Ring C; Klaus J; Reinshagen M
    Z Gastroenterol; 2003 Dec; 41(12):1145-50. PubMed ID: 14661123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there an association between coeliac disease and inflammatory bowel diseases? A study of relative prevalence in comparison with population controls.
    Leeds JS; Höroldt BS; Sidhu R; Hopper AD; Robinson K; Toulson B; Dixon L; Lobo AJ; McAlindon ME; Hurlstone DP; Sanders DS
    Scand J Gastroenterol; 2007 Oct; 42(10):1214-20. PubMed ID: 17918008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease.
    Summers RW; Elliott DE; Qadir K; Urban JF; Thompson R; Weinstock JV
    Am J Gastroenterol; 2003 Sep; 98(9):2034-41. PubMed ID: 14499784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosoma mansoni adult microsomal antigens, a serologic reagent. II. Specificity of antibody responses to the S. mansoni microsomal antigen (MAMA).
    Tsang VC; Hancock K; Kelly MA; Wilson BC; Maddison SE
    J Immunol; 1983 Mar; 130(3):1366-70. PubMed ID: 6185578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study.
    Bernstein CN; Wajda A; Blanchard JF
    Gastroenterology; 2005 Sep; 129(3):827-36. PubMed ID: 16143122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
    Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
    Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of inflammatory bowel disease in patients with airways disease.
    Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
    Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication profiles of patients in the University of Puerto Rico inflammatory bowel disease registry.
    Meléndez JD; Larregui Y; Vázquez JM; Carlo VL; Torres EA
    P R Health Sci J; 2011 Mar; 30(1):3-8. PubMed ID: 21449490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between corticosteroid use and development of fractures among IBD patients in a population-based database.
    Bernstein CN; Blanchard JF; Metge C; Yogendran M
    Am J Gastroenterol; 2003 Aug; 98(8):1797-801. PubMed ID: 12907335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perianal disease predicts changes in Crohn's disease phenotype-results of a population-based study of inflammatory bowel disease phenotype.
    Tarrant KM; Barclay ML; Frampton CM; Gearry RB
    Am J Gastroenterol; 2008 Dec; 103(12):3082-93. PubMed ID: 19086959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases.
    Ludwiczek O; Kaser A; Tilg H
    Int J Colorectal Dis; 2003 Mar; 18(2):142-7. PubMed ID: 12548417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.